On the antiatherogenic effects of vitamin E: the search for the Holy Grail

Commentary

(1476) Views  (839) Full article downloads

Authors: Francesco Galli, Dimitrios Kirmizis, Dimitrios Chatzidimitriou

Published Date February 2010 Volume 2010:6 Pages 69 - 71

DOI: http://dx.doi.org/10.2147/VHRM.S9289

In a recent edition of Vascular Health and Risk Management, Kirmizis and Chatzidimitriou have published a review article, “Antiatherogenic effects of vitamin E: the search for the Holy Grail”.

Beside a general evaluation of the literature on vitamin E and CVD prevention, the authors pointed out the possibility that vitamin E therapy may have particular efficacy in kidney patients. In this sense, they may represent an elective population with high susceptibility to such a secondary prevention effect, that was not identified in other cardiovascular (CVD) patient populations studied in the largest randomized controlled trials.